# clm_521ADD71267C

subject: Bristol-Myers Squibb (/record/bristol-myers-squibb.md)  
predicate: quarterly_research_and_development  
value: 2,257,000,000 United States dollar  
valid_from: 2025-03-31  
valid_to: 2025-06-30  
published: 2025-04-24  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_8BF1DFD17C30  
last_updated: 2026-11-08  
cite: AsOf. "Bristol-Myers Squibb quarterly research and development: 2,257,000,000 United States dollar", as of 2025-03-31 (until 2025-06-30). Claim clm_521ADD71267C, https://asof.is/claim/clm_521ADD71267C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2025, filed 2025-04-24  

## Sources

- https://www.sec.gov/Archives/edgar/data/14272/000001427225000091/0000014272-25-000091-index.htm (primary, SEC EDGAR 10-Q Q1 FY2025, published 2025-04-24)

## Supersedes

- [Bristol-Myers Squibb](/record/bristol-myers-squibb.md) | quarterly_research_and_development | 2,374,000,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_521ADD71267C](/claim/clm_521ADD71267C.md) | [clm_D5943AFEC8DF](/claim/clm_D5943AFEC8DF.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.